THOMSON MEDICAL GROUP LIMITED
SGX: A50 (Thomson Medical)
Last update: 3 hours ago0.048
0.00 (4.35%)
| Previous Close | 0.046 |
| Volume | 353,000 |
| Price / Sales | 2.90 |
| Price / Book | 2.75 |
| 52 Weeks Range |
| Profit Margin | 0.13% |
| Operating Margin (TTM) | 9.99% |
| Quarterly Revenue Growth (YOY) | 18.00% |
| Quarterly Earnings Growth (YOY) | -2.50% |
| Total Debt/Equity (MRQ) | 188.92% |
| Current Ratio (MRQ) | 0.870 |
| Operating Cash Flow (TTM) | -20.46 M |
| Levered Free Cash Flow (TTM) | -120.28 M |
| Return on Assets (TTM) | 1.42% |
| Return on Equity (TTM) | 0.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (SG) | Mixed | Mixed |
| Medical Care Facilities (Global) | Bullish | Mixed | |
| Stock | Thomson Medical | Mixed | Bearish |
AIStockmoo Score
| Value 35% | -4.5 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -4.5 |
| Timing 35% | -0.6 |
| AI Technical info | NA |
| Technical Oscillators info | -1.0 |
| Technical Moving Averages info | 0.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| Environment | ×1.22 |
| Macro Environment info | -3.4 |
| Sector vs Market (6M) | -18.9% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 3.0 |
| Final Score | -2.71 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| THOMSON MEDICAL | - | - | - | 2.75 |
| IHH | - | 1.16% | - | 2.16 |
| RAFFLES MEDICAL | - | 3.57% | - | 1.49 |
| B WILSHIRE LTD | - | - | - | 1.02 |
| LIVINGSTONE | - | - | - | 2.10 |
| OUE HEALTHCARE | - | - | - | 1.59 |
Select this tab to load the latest available analysis.
|
Thomson Medical Group Ltd is a provider of healthcare services for women and children. Its segments include Hospital services; Specialised services and Investment holdings. It generates maximum revenue from the Specialised services segment. The specialised services segment includes services provided by fertility clinics, paediatric centres, cancer centre, cardiology centre, Chinese medicine, specialist skin centre and a pre-natal and clinical diagnostic laboratory and project-related services such as managing vaccination centres, COVID-19 Treatment Facilities and Transitional Care Facilities. It also includes a consumer business segment, comprising products and services. Geographically, it derives a majority of its revenue from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 90.03% |
| % Held by Institutions | 0.08% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Lim (Eng Hock) | 13 Sep 2024 | 23,725,309,427 (89.73%) |
| 5Y Average Dividend Yield | 0.46% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 24 Oct 2023 | 26 Sep 2023 | 03 Nov 2023 | 0.0004 Cash |
| 07 Nov 2022 | 14 Oct 2022 | 17 Nov 2022 | 0.00115 Cash |
| 02 Nov 2021 | 11 Oct 2021 | 12 Nov 2021 | 0.00015 Cash |
| 14 May 2019 | 01 Mar 2019 | 28 May 2019 | 0.00025 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2023 | 0.000 | 1 | 0.66 |
| 2022 | 0.001 | 1 | 1.47 |
| 2021 | 0.000 | 1 | 0.18 |
| 2019 | 0.000 | 1 | 0.39 |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |